Literature DB >> 12193648

Prospective isolation of human clonogenic common myeloid progenitors.

Markus G Manz1, Toshihiro Miyamoto, Koichi Akashi, Irving L Weissman.   

Abstract

The hierarchical development from hematopoietic stem cells to mature cells of the hematolymphoid system involves progressive loss of self-renewal capacity, proliferation ability, and lineage potentials. Here we show the prospective isolation of early developmental intermediates, the human clonogenic common myeloid progenitors and their downstream progeny, the granulocyte/macrophage and megakaryocyte/erythrocyte progenitors. All three populations reside in the lineage-negative (lin(-)) CD34(+)CD38(+) fraction of adult bone marrow as well as in cord blood. They are distinguishable by the expression of the IL-3R alpha chain, the receptor of an early-acting hematopoietic cytokine, and CD45RA, an isoform of a phosphotyrosine phosphatase involved in negative regulation of cytokine signaling. Multipotent progenitors, early lymphoid progenitors, and the here-defined myeloid progenitors express distinct profiles of hematopoiesis-affiliated genes. The isolation of highly purified hematopoietic intermediates provides tools to better understand developmental programs underlying normal and leukemic hematopoiesis.

Entities:  

Mesh:

Year:  2002        PMID: 12193648      PMCID: PMC129361          DOI: 10.1073/pnas.172384399

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Different expression of CD41 on human lymphoid and myeloid progenitors from adults and neonates.

Authors:  N Debili; C Robin; V Schiavon; R Letestu; F Pflumio; M T Mitjavila-Garcia; L Coulombel; W Vainchenker
Journal:  Blood       Date:  2001-04-01       Impact factor: 22.113

2.  A clonogenic common myeloid progenitor that gives rise to all myeloid lineages.

Authors:  K Akashi; D Traver; T Miyamoto; I L Weissman
Journal:  Nature       Date:  2000-03-09       Impact factor: 49.962

3.  Development of CD8alpha-positive dendritic cells from a common myeloid progenitor.

Authors:  D Traver; K Akashi; M Manz; M Merad; T Miyamoto; E G Engleman; I L Weissman
Journal:  Science       Date:  2000-12-15       Impact factor: 47.728

4.  Dendritic cell potentials of early lymphoid and myeloid progenitors.

Authors:  M G Manz; D Traver; T Miyamoto; I L Weissman; K Akashi
Journal:  Blood       Date:  2001-06-01       Impact factor: 22.113

5.  CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling.

Authors:  J Irie-Sasaki; T Sasaki; W Matsumoto; A Opavsky; M Cheng; G Welstead; E Griffiths; C Krawczyk; C D Richardson; K Aitken; N Iscove; G Koretzky; P Johnson; P Liu; D M Rothstein; J M Penninger
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

6.  Individual CD34+CD38lowCD19-CD10- progenitor cells from human cord blood generate B lymphocytes and granulocytes.

Authors:  A C Berardi; E Meffre; F Pflumio; A Katz; W Vainchenker; C Schiff; L Coulombel
Journal:  Blood       Date:  1997-05-15       Impact factor: 22.113

7.  CD9 and megakaryocyte differentiation.

Authors:  D Clay; E Rubinstein; Z Mishal; A Anjo; M Prenant; C Jasmin; C Boucheix; M C Le Bousse-Kerdilès
Journal:  Blood       Date:  2001-04-01       Impact factor: 22.113

8.  Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines.

Authors:  M Kondo; D C Scherer; T Miyamoto; A G King; K Akashi; K Sugamura; I L Weissman
Journal:  Nature       Date:  2000-09-21       Impact factor: 49.962

9.  Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl/c-Kit signaling the other.

Authors:  J Domen; I L Weissman
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

10.  BCL-2 cooperates with promyelocytic leukemia retinoic acid receptor alpha chimeric protein (PMLRARalpha) to block neutrophil differentiation and initiate acute leukemia.

Authors:  S C Kogan; D E Brown; D B Shultz; B T Truong; V Lallemand-Breitenbach; M C Guillemin; E Lagasse; I L Weissman; J M Bishop
Journal:  J Exp Med       Date:  2001-02-19       Impact factor: 14.307

View more
  187 in total

1.  Natural killer-cell differentiation by myeloid progenitors.

Authors:  Bartosz Grzywacz; Nandini Kataria; Niketa Kataria; Bruce R Blazar; Jeffrey S Miller; Michael R Verneris
Journal:  Blood       Date:  2010-12-20       Impact factor: 22.113

2.  Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS.

Authors:  Laura Barreyro; Britta Will; Boris Bartholdy; Li Zhou; Tihomira I Todorova; Robert F Stanley; Susana Ben-Neriah; Cristina Montagna; Samir Parekh; Andrea Pellagatti; Jacqueline Boultwood; Elisabeth Paietta; Rhett P Ketterling; Larry Cripe; Hugo F Fernandez; Peter L Greenberg; Martin S Tallman; Christian Steidl; Constantine S Mitsiades; Amit Verma; Ulrich Steidl
Journal:  Blood       Date:  2012-06-21       Impact factor: 22.113

3.  Origins of tumor-associated macrophages and neutrophils.

Authors:  Virna Cortez-Retamozo; Martin Etzrodt; Andita Newton; Philipp J Rauch; Aleksey Chudnovskiy; Cedric Berger; Russell J H Ryan; Yoshiko Iwamoto; Brett Marinelli; Rostic Gorbatov; Reza Forghani; Tatiana I Novobrantseva; Victor Koteliansky; Jose-Luiz Figueiredo; John W Chen; Daniel G Anderson; Matthias Nahrendorf; Filip K Swirski; Ralph Weissleder; Mikael J Pittet
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

4.  Developing and mature human granulocytes express ELP 6 in the cytoplasm.

Authors:  Lori A Wagner; Shuping Wang; Elizabeth A Wayner; Clarissa Christensen; Sherrie J Perkins; Gavin W Ward; Robert B Weiss; Diane M Dunn; Michael J Redd; Gerald J Spangrude; Gerald J Gleich
Journal:  Hum Antibodies       Date:  2013

5.  Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes.

Authors:  Wendy W Pang; John V Pluvinage; Elizabeth A Price; Kunju Sridhar; Daniel A Arber; Peter L Greenberg; Stanley L Schrier; Christopher Y Park; Irving L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-06       Impact factor: 11.205

6.  Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropenia.

Authors:  Andrew BitMansour; Thai M Cao; Stephanie Chao; Sumana Shashidhar; Janice M Y Brown
Journal:  Blood       Date:  2004-12-02       Impact factor: 22.113

Review 7.  TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells.

Authors:  Yoshikane Kikushige; Toshihiro Miyamoto
Journal:  Int J Hematol       Date:  2013-09-18       Impact factor: 2.490

8.  The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages.

Authors:  Hiromi Iwasaki; Shin-ichi Mizuno; Yojiro Arinobu; Hidetoshi Ozawa; Yasuo Mori; Hirokazu Shigematsu; Kiyoshi Takatsu; Daniel G Tenen; Koichi Akashi
Journal:  Genes Dev       Date:  2006-11-01       Impact factor: 11.361

Review 9.  Right on target: eradicating leukemic stem cells.

Authors:  Daniela S Krause; Richard A Van Etten
Journal:  Trends Mol Med       Date:  2007-11-05       Impact factor: 11.951

10.  Trisomy 21 enhances human fetal erythro-megakaryocytic development.

Authors:  Stella T Chou; Joanna B Opalinska; Yu Yao; Myriam A Fernandes; Anna Kalota; John S J Brooks; John K Choi; Alan M Gewirtz; Gwenn-ael Danet-Desnoyers; Richard L Nemiroff; Mitchell J Weiss
Journal:  Blood       Date:  2008-09-23       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.